Tumimpad, Cherry .
HRN: 25-78-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2024
CEFUROXIME 500MG (TAB)
08/29/2024
09/05/2024
ORAL
500mg
BID
S/P NSD W/ RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes